CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors.
about
Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.Toxoplasma gondii is dependent on glutamine and alters migratory profile of infected host bone marrow derived immune cells through SNAT2 and CXCR4 pathways.MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice.Aqp1 enhances migration of bone marrow mesenchymal stem cells through regulation of FAK and β-catenin.Cell-autonomous heparanase modulates self-renewal and migration in bone marrow-derived mesenchymal stem cellsThe role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression.Encapsulated stem cells for cancer therapy.The role of catecholamines in mesenchymal stem cell fate.Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis.Anti‑angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt‑1.Skin-derived mesenchymal stem cells as quantum dot vehicles to tumors.Reconstruction of orbital defects by implantation of antigen-free bovine cancellous bone scaffold combined with bone marrow mesenchymal stem cells in rats.Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating Runx2.
P2860
Q34038859-A5233F81-660F-4406-8B7C-D97FB29831E3Q34317872-C8B43AB3-55FF-4A6F-AE9F-EE1A4D1F1547Q34985576-B60124B4-102A-4FA3-A453-7A00B11FA582Q35826470-EEFC4EF2-C97D-47DE-A6C9-23CE44DECA3CQ37409084-093007CD-3915-48D9-92E3-21A43896360BQ37716635-42EFC310-8740-4A22-AF48-CA9939C0F1FEQ38010997-7F0A4709-BC46-4F9D-B258-D4A78B1FFB00Q38090923-3A79E502-DF0A-45EF-97EA-5CBF349A71F2Q38244904-D46FCF91-1AD9-477E-B462-ADB483DD2DE2Q38829699-C2320498-8947-4467-BBAE-D18B6B861BF1Q39432344-6D92DCEA-5071-4F12-972D-BFC51A147D4BQ42057790-5F1D1BB3-53B6-4B61-83A0-4D689696759FQ45871288-7EC7D209-FBA2-46DF-8E21-B8D85D441FF2Q47133839-28A173C4-F887-4024-BDBE-BF03DCDB6F03Q50482604-5FB8620A-2BFA-400D-8F69-021DCC0A27DCQ53099889-856AE524-E954-4CC7-A4DE-2CD01C764B23
P2860
CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CXCR4 and matrix metalloprotei ...... ing and engraftment to tumors.
@en
CXCR4 and matrix metalloprotei ...... ing and engraftment to tumors.
@nl
type
label
CXCR4 and matrix metalloprotei ...... ing and engraftment to tumors.
@en
CXCR4 and matrix metalloprotei ...... ing and engraftment to tumors.
@nl
prefLabel
CXCR4 and matrix metalloprotei ...... ing and engraftment to tumors.
@en
CXCR4 and matrix metalloprotei ...... ing and engraftment to tumors.
@nl
P1433
P1476
CXCR4 and matrix metalloprotei ...... ming and engraftment to tumors
@en
P2093
P304
P356
10.3109/14653249.2010.542457
P50
P577
2010-12-20T00:00:00Z